- Home
- HHS vs SCNX Comparison
HHS vs SCNX Comparison
Compare HHS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- SCNX
- Stock Information
- Founded
- HHS 1923
- SCNX 2010
- Country
- HHS United States
- SCNX United States
- Employees
- HHS N/A
- SCNX N/A
- Industry
- HHS Advertising
- SCNX Other Pharmaceuticals
- Sector
- HHS Consumer Discretionary
- SCNX Health Care
- Exchange
- HHS Nasdaq
- SCNX Nasdaq
- Market Cap
- HHS 39.4M
- SCNX 33.6M
- IPO Year
- HHS N/A
- SCNX 2020
- Fundamental
- Price
- HHS $5.05
- SCNX $2.80
- Analyst Decision
- HHS
- SCNX
- Analyst Count
- HHS 0
- SCNX 0
- Target Price
- HHS N/A
- SCNX N/A
- AVG Volume (30 Days)
- HHS 17.7K
- SCNX 10.3K
- Earning Date
- HHS 03-13-2025
- SCNX 03-04-2025
- Dividend Yield
- HHS N/A
- SCNX N/A
- EPS Growth
- HHS N/A
- SCNX N/A
- EPS
- HHS N/A
- SCNX 3.55
- Revenue
- HHS $187,604,000.00
- SCNX N/A
- Revenue This Year
- HHS N/A
- SCNX $1,085.75
- Revenue Next Year
- HHS $4.05
- SCNX N/A
- P/E Ratio
- HHS N/A
- SCNX $1.18
- Revenue Growth
- HHS N/A
- SCNX 166.67
- 52 Week Low
- HHS $4.85
- SCNX $2.61
- 52 Week High
- HHS $8.87
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- HHS 38.02
- SCNX N/A
- Support Level
- HHS $5.31
- SCNX N/A
- Resistance Level
- HHS $5.33
- SCNX N/A
- Average True Range (ATR)
- HHS 0.19
- SCNX 0.00
- MACD
- HHS -0.02
- SCNX 0.00
- Stochastic Oscillator
- HHS 9.26
- SCNX 0.00
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.